Literature DB >> 16214645

Transfusion management in sickle cell disease.

Sam O Wanko1, Marilyn J Telen.   

Abstract

Sickle cell disease (SCD) is the most commonly inherited hemoglobinopathy in the United States. Blood transfusion is a critical part of the multidisciplinary approach necessary in the management of SCD; however, blood transfusions are not without complications. The successful use of transfusion as a treatment strategy in SCD requires the critical review and knowledge of transfusion methods, generally accepted indications, clinical situations in which transfusion generally is not considered, the selection of blood products, and strategies to prevent transfusion-related complications.

Entities:  

Mesh:

Year:  2005        PMID: 16214645     DOI: 10.1016/j.hoc.2005.07.002

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  13 in total

1.  Current therapy of sickle cell disease.

Authors:  Zakari Y Aliyu; Ashaunta R Tumblin; Gregory J Kato
Journal:  Haematologica       Date:  2006-01       Impact factor: 9.941

2.  A rapid paper-based test for quantifying sickle hemoglobin in blood samples from patients with sickle cell disease.

Authors:  Nathaniel Z Piety; Xiaoxi Yang; Dalia Lezzar; Alex George; Sergey S Shevkoplyas
Journal:  Am J Hematol       Date:  2015-03-30       Impact factor: 10.047

3.  Frequency, pattern, and associations of renal iron accumulation in sickle/β-thalassemia patients.

Authors:  Antonella Meloni; Luigi Barbuto; Laura Pistoia; Vincenzo Positano; Stefania Renne; Giuseppe Peritore; Priscilla Fina; Anna Spasiano; Massimo Allò; Giuseppe Messina; Tommaso Casini; Antonella Massa; Luigia Romano; Alessia Pepe; Filippo Cademartiri
Journal:  Ann Hematol       Date:  2022-07-11       Impact factor: 4.030

Review 4.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

5.  Simple chronic transfusion therapy, a crucial therapeutic option for sickle cell disease, improves but does not normalize blood rheology: What should be our goals for transfusion therapy?

Authors:  Jon A Detterich
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

Review 6.  Surgical management of osteonecrosis of the femoral head in patients with sickle cell disease.

Authors:  Atul F Kamath; Michael H McGraw; Craig L Israelite
Journal:  World J Orthop       Date:  2015-11-18

7.  Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease.

Authors:  Marion E Reid; Christine Halter Hipsky; Kim Hue-Roye; Carolyn Hoppe
Journal:  Blood Cells Mol Dis       Date:  2013-12-02       Impact factor: 3.039

8.  A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.

Authors:  Elliott Vichinsky; Onyinye Onyekwere; John Porter; Paul Swerdlow; James Eckman; Peter Lane; Beatrice Files; Kathryn Hassell; Patrick Kelly; Felicia Wilson; Françoise Bernaudin; Gian Luca Forni; Iheanyi Okpala; Catherine Ressayre-Djaffer; Daniele Alberti; Jaymes Holland; Peter Marks; Ellen Fung; Roland Fischer; Brigitta U Mueller; Thomas Coates
Journal:  Br J Haematol       Date:  2007-02       Impact factor: 6.998

9.  Pattern and prevelence of alloimmunization in multiply transfused patients with sickle cell disease in Nigeria.

Authors:  Umar Kangiwa; Obike Ibegbulam; Sunday Ocheni; Anazoeze Madu; Ndakosu Mohammed
Journal:  Biomark Res       Date:  2015-10-13

10.  Anti-Toxoplasma gondii antibodies in patients with beta-hemoglobinopathies: the first report in the Americas.

Authors:  Marina Neves Ferreira; Claudia Regina Bonini-Domingos; Isabeth Fonseca Estevão; Clarice Lopes de Castro Lobo; Gisele Cristina Souza Carrocini; Aparecida Perpétuo Silveira-Carvalho; Octávio Ricci; Luiz Carlos de Mattos; Cinara Cássia Brandão de Mattos
Journal:  BMC Res Notes       Date:  2017-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.